(NYSE: SCL) Stepan Co's forecast annual revenue growth rate of 4.72% is not forecast to beat the US Specialty Chemicals industry's average forecast revenue growth rate of 6.51%, and while it is not forecast to beat the US market's average forecast revenue growth rate of 11.65%.
Stepan Co's revenue in 2026 is $2,534,658,000.On average, 3 Wall Street analysts forecast SCL's revenue for 2026 to be $60,064,974,362, with the lowest SCL revenue forecast at $57,996,120,211, and the highest SCL revenue forecast at $62,747,664,360. On average, 3 Wall Street analysts forecast SCL's revenue for 2027 to be $63,611,581,478, with the lowest SCL revenue forecast at $61,338,115,378, and the highest SCL revenue forecast at $66,544,352,747.
In 2028, SCL is forecast to generate $65,975,986,222 in revenue, with the lowest revenue forecast at $63,929,866,732 and the highest revenue forecast at $68,681,410,881.